HIF1A and B-cell chronic lymphocytic leukemia: In addition, because HIF-1α is an important regulator of immune cell functions [11], EZN-2208 may also interfere with the supporting action of lymphoid or myeloid immune regulators that promote CLL maintenance and proliferation [12].